Download in electronic PDF format for $35



Search the Complete Journal Archives

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1

Author(s):  Martin Matt

Issue:  Sep/Oct 2018 - Volume 22, Number 5
View All Articles in Issue

Abstract:  Compounders engaged in making sterile preparations need to employ a quality assurance system of documented policies and procedures to attempt to reduce the possibility of contamination. The quality-assurance program will be monitored through the facility’s quality control system. Compounders should be aware of the requirements of each state they are licensed in as well as the inspection observations commonly noted in 483s issued by the U.S. Food and Drug Administration. In part 1 of this 2-part article, we discuss the currently evolving regulatory environment and why sterile compounding requires planning and monitoring to deliver quality compounds to patients. Part 2 will examine the United States Pharmacopeia’s discussion on the principles of quality assurance and quality control in sterile compounding.

Related Keywords: Matt Martin, PharmD, United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, USP, compounded sterile preparations, sterility testing, regulation compliance, regulatory requirements, United States Food and Drug Administration Form 483, FDA Form 483, pharmacy inspection, quality control, drug safety, compound contamination, microbial contaminants, sterility assurance

Related Categories: BUSINESS, LEGAL, STERILE PREPARATIONS, SUPPORT, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt Sep/Oct 2018 401-404 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Martin Matt Nov/Dec 2018 475-478 Buy
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin Sep/Oct 2018 387-398 Buy
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations McElhiney Linda F Jul/Aug 2013 307-311 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2008 440-443 Buy
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Newton David W Jul/Aug 2013 283-288 Buy
Microbiologic Testing for 503A Sterile-Compounding Pharmacies Mixon William, Roth Abby May/Jun 2017 193-203 Buy
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Martin Matt Jul/Aug 2018 303-312 Buy